Acadia Pharmaceuticals (ACAD) Reports Q3 Loss of $0.42, Beats by 3c
More News related to ACAD
- ACADIA Pharmaceuticals to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009
- Barclays Gets Bullish On US Biotechnology Sector (BBH)
- ACADIA Pharmaceuticals to Present at the Eighth Annual JMP Securities Research Conference on May 19, 2009
- Acadia Pharma (ACAD) Misses Q1 View By 4c
- ACADIA Pharmaceuticals Reports First Quarter 2009 Financial Results
Acadia Pharmaceuticals (Nasdaq: ACAD) reports Q3 loss of $0.42, 3 cents better than the analyst estimate of ($0.45). Revenue for the quarter was $282K, versus the consensus of $1.05 million.
Related Categories
EarningsStocks Mentioned
-0.13Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
